Wolverine Trading
AMED

Wolverine Trading’s Amedisys AMED Stock Holding History

Wolverine Trading’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,282
Closed -$567K – 4410
2022
Q1 		$567K Buy
+3,282
New +$490K ﹤0.01% 3069
2020
Q2 		– Sell
-2,222
Closed -$400K – 4518
2020
Q1 		$400K Buy
2,222
+1,007
+83% +$179K ﹤0.01% 2903
2019
Q4 		$203K Buy
+1,215
New +$181K ﹤0.01% 3995
2019
Q1 		– Sell
-2,930
Closed -$336K – 4463
2018
Q4 		$336K Sell
2,930
-8,626
-75% -$1.02M ﹤0.01% 3067
2018
Q3 		$1.44M Buy
+11,556
New +$1.28M ﹤0.01% 1970

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Wolverine Trading's AMED Position: Q2 2022 in Review

Wolverine Trading sold out of Amedisys (AMED) in Q2 2022, closing a stake of 3,282 shares — an estimated $567K sold.

Wolverine Trading first reported a position in AMED in Q3 2018 and held it in 5 quarters. The position peaked at $1.44M in Q3 2018. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Wolverine Trading reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 3,282 Amedisys shares in Q2 2022, an estimated $567K.
  • Wolverine Trading first reported a position in Amedisys in Q3 2018 and held it in 5 quarters.
  • Wolverine Trading's Amedisys position peaked at $1.44M in Q3 2018.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.